Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch

NCT00965913 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Nicotine Patch
DRUG: Nicotine Patch Comparator
DRUG: Placebo Patch

Sponsor

McNeil AB